enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Tucatinib - Wikipedia

   en.wikipedia.org/wiki/Tucatinib

   Tucatinib, sold under the brand name Tukysa, is an anticancer medication used for the treatment of HER2-positive breast cancer. [3] [4] It is a small molecule inhibitor of HER2. [6] [7] It was developed by Array BioPharma and licensed to Cascadian Therapeutics (formerly Oncothyreon, subsequently part of Seattle Genetics). [8]

3. Trastuzumab - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab

   Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. [30] [27] [31] [32] It is specifically used for cancer that is HER2 receptor positive. [30]

4. List of drugs granted breakthrough therapy designation

   en.wikipedia.org/wiki/List_of_drugs_granted...

   granted for three indications: HER2-positive breast cancer with prior anti-HER2-based treatment; HER2 low (IHC 1+ or IHC 2+/ISH) breast cancer; and non-small cell-lung cancer with an activating HER2 mutation Dupilumab: Regeneron Pharmaceuticals: granted for two indications: eosinophilic esophagitis; and atopic dermatitis: Ivosidenib: Servier ...

5. Drugs for advanced breast cancer could help patients with ...

   www.aol.com/drugs-advanced-breast-cancer-could...

   Researchers explored the use of the treatment for other cancers, including that of the bile ducts.

6. Here’s how to pay the lowest prices for your prescription ...

   www.aol.com/finance/pay-lowest-prices...

   With Extra Help, your Part D premium and deductible are both $0 and you’ll pay no more than $4.50 for each generic drug and a maximum of $11.20 for each brand-name drug. Once the total drug ...

7. New breast cancer drugs to benefit thousands - AOL

   www.aol.com/breast-cancer-drugs-benefit...

   For premium support please call: 800-290-4726 more ways to reach us

8. Trastuzumab deruxtecan - Wikipedia

   en.wikipedia.org/wiki/Trastuzumab_deruxtecan

   Trastuzumab deruxtecan is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting and for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal ...

9. HER2 - Wikipedia

   en.wikipedia.org/wiki/HER2

   As of November 2015, there are a number of ongoing and recently completed clinical trials of novel targeted agents for HER2+ metastatic breast cancer, e.g. margetuximab. [36] Additionally, NeuVax (Galena Biopharma) is a peptide-based immunotherapy that directs "killer" T cells to target and destroy cancer cells that express HER2. It has entered ...